Psychiatry & Neurology, Addiction Medicine · Lees Summit, MO
NPI
1689661829
Since 2005
Specialty
Psychiatry & Neurology, Addiction Medicine
Code 2084A0401X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
4025 NE Lakewood Way Ste 210
Lees Summit, MO, 64064
Phone (816) 554-7750
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
538 services
Medicare patients, 2024
93
Average age 66
Drug cost, 2024
$2.6M
8,992 prescriptions
Company payments, 2025
$45K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Subbu J Sarma was code 99214 (office e&m - established), 124 times for 43 patients. In total Subbu J Sarma billed 538 services in 15 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 124 | 43 | $83.82 | $10K |
| 99214 Office E&M - Established | Facility | 78 | 15 | $69.38 | $5,412 |
| 90833 Psychotherapy - Nongroup | Office | 73 | 26 | $52.94 | $3,865 |
| 99213 Office E&M - Established | Facility | 68 | 13 | $48.80 | $3,318 |
| 99349 Home E&M - New and Established | Office | 58 | 21 | $85.52 | $4,960 |
| 99348 Home E&M - New and Established | Office | 55 | 20 | $47.58 | $2,617 |
| 99213 Office E&M - Established | Office | 18 | 14 | $51.01 | $918 |
By year: 2022 $48K for 770 services; 2023 $36K for 539 services; 2024 $36K for 538 services.
Medicare prescription drug claims, 2024
In 2024, the drug Subbu J Sarma prescribed most often to Medicare patients was Clozapine, with 536 prescriptions and refills. In total Subbu J Sarma wrote 8,992 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clozapine Generic | 536 | 536 | 26 | $44K |
| Trazodone Hcl Generic | 499 | 566 | 58 | $9,994 |
| Benztropine Mesylate Generic | 457 | 458 | 39 | $8,920 |
| Clonazepam Generic | 437 | 442 | 38 | $7,009 |
| Aripiprazole Generic | 394 | 449 | 46 | $30K |
| Lorazepam Generic | 314 | 320 | 33 | $5,391 |
| Sertraline Hcl Generic | 304 | 345 | 33 | $4,943 |
| Risperidone Generic | 301 | 318 | 28 | $8,970 |
| Quetiapine Fumarate Generic | 218 | 288 | 24 | $5,529 |
| Divalproex Sodium Generic | 217 | 218 | 19 | $10K |
| Divalproex Sodium Er Divalproex Sodium | 215 | 216 | 23 | $23K |
| Buspirone Hcl Generic | 215 | 238 | 21 | $7,287 |
| Lamotrigine Generic | 209 | 253 | 21 | $3,233 |
| Invega Sustenna Paliperidone Palmitate | 201 | 201 | 17 | $646K |
| Fluoxetine Hcl Generic | 196 | 226 | 17 | $4,187 |
Brand drugs: 939 claims; generic drugs: 8,053 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Subbu J Sarma $45K ($45K in general payments such as food, travel and fees) from 15 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $30K.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 48 | $30K |
| E.R. Squibb & Sons, L.L.C. BMY | 46 | $13K |
| Axsome Therapeutics, Inc. AXSM | 11 | $379 |
| Vanda Pharmaceuticals Inc. VNDA | 10 | $259 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 15 | $258 |
| Janssen Pharmaceuticals, Inc JNJ | 9 | $163 |
| Alkermes, Inc. ALKS | 8 | $158 |
| Abbvie Inc. ABBV | 8 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $99.9 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $64.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.